Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial

(2018) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial

(2017) Alice Gottlieb et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

(2015) Diamant Thaçi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis

(2014) A. Langenbruch et al.   BRITISH JOURNAL OF DERMATOLOGY

Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

(2014) D. Thaçi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)

(2014) C. Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

(2014) Richard G. Langley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes

(2013) M. Augustin et al.   BRITISH JOURNAL OF DERMATOLOGY

Disease characteristics in patients with and without psoriatic arthritis treated with etanercept

(2013) K. Papp et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

(2012) K.A. Papp et al.   BRITISH JOURNAL OF DERMATOLOGY

Cytokine-Based Therapy in Psoriasis

(2012) Anupam Mitra et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

The Burden of Nail Psoriasis: An Introduction

(2010) Robert Baran   DERMATOLOGY

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

(2010) W. Hueber et al.   Science Translational Medicine

The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?

(2009) Dennis McGonagle et al.   CURRENT OPINION IN RHEUMATOLOGY

Approach to managing patients with nail psoriasis

(2009) K Reich   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Growth rate of human fingernails and toenails in healthy American young adults

(2009) S Yaemsiri et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Interleukin-17 as a drug target in human disease

(2009) Stefan Ivanov et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

(2007) Phoebe Rich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY